METTL3 and gastric cancer: In gastric cancer, global dysregulation of the m6A machinery has also been documented, with METTL3, FTO, YTHDFs, IGF2BPs and hnRNPA2B1 frequently upregulated in patient tissues and associated with poor prognosis, advanced stages and metastasis [42].